Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study

Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study

Yujing Tan,1,* Hanfang Jiang,2,* Xinzhu Tian,1,* Fei Ma,1 Jiayu Wang,1 Pin Zhang,1 Binghe Xu,1 Ying Fan,1 Weihong Zhao3 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences &a...

Full description

Saved in:
Bibliographic Details
Main Authors: Tan Y, Jiang H, Tian X, Ma F, Wang J, Zhang P, Xu B, Fan Y, Zhao W
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Breast Cancer: Targets and Therapy
Subjects:
nolus
advanced breast cancer
everolimus
multicenter
efficacy
Online Access:https://www.dovepress.com/non-luminal-disease-score-for-everolimus-in-patients-withhormone-recep-peer-reviewed-fulltext-article-BCTT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/non-luminal-disease-score-for-everolimus-in-patients-withhormone-recep-peer-reviewed-fulltext-article-BCTT

Similar Items